BATS BZX Real-Time Price
As of 3:01pm ET
| +6.78 / +2.67%|
The 8 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 322.50, with a high estimate of 385.00 and a low estimate of 300.00. The median estimate represents a +23.79% increase from the last price of 260.53.
The current consensus among 9 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.